JPMorgan analyst Jeffrey Zekauskas lowered his price target for Mosaic to $24 from $27 to reflect lower year-over-year phosphate margins. However, Mosaic is taking steps to meet its near-term challenges, Zekauskas tells investors in a research note. He also believes the company is trying to create shareholder value independent of changes in the fertilizer markets. And despite the rise in Mosaic's share price month-to-date, the stock continues trade at six-times EBITDA for 2020 with a 6.5% free cash flow yield, adds the analyst. As such, he keeps an Overweight rating on Mosaic.